Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.97

Antiprotozoal agents

Antiprotozoal agents treat malaria, leishmaniasis, toxoplasmosis, babesiosis, trypanosomiasis, and luminal protozoal infections; the parasite species and disease stage, not one universal drug, dictate the regimen. Artemisinin combination therapy is first-line for malaria, liposomal amphotericin B for visceral leishmaniasis, and pyrimethamine-sulfadiazine-leucovorin for toxoplasmic encephalitis.

11 min read5 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Antiprotozoal agents treat infections from single-celled eukaryotic parasites: Plasmodium (malaria), Leishmania, Toxoplasma gondii, Babesia microti, Trypanosoma species, and the luminal protozoa Giardia, Entamoeba, and Trichomonas.

  • Epidemiology

    Malaria drives most antiprotozoal prescribing worldwide, concentrated in sub-Saharan Africa, South Asia, and South America; most United States cases are imported.

  • Risk factors

    Travel to an endemic area without chemoprophylaxis: the leading risk factor for imported malaria in a nonimmune host.

  • Pathophysiology

    4-aminoquinolines (chloroquine, hydroxychloroquine): block detoxification of heme into inert hemozoin in the plasmodial digestive vacuole; free heme accumulates and is toxic.

  • Clinical features

    Effects and adverse profiles vary widely by agent.

  • Differential diagnosis

    Agent selection is a differential among competing drugs, each chosen for a specific discriminator.

  • Diagnosis

    Species identification and disease staging drive drug choice more than any laboratory parameter.

  • Management

    Uncomplicated malaria, first-line: Artemether-lumefantrine 4 tablets PO as a 5-day, 10-dose course (initial dose, second dose 8 hours later, then twice daily on days 2-5).

  • Complications

    Toxicity clusters by mechanism: hemolysis with 8-aminoquinolines in G6PD deficiency, QT prolongation with quinine, mefloquine, and antimonials, marrow suppression with pyrimethamine.

  • Prognosis

    With prompt species-appropriate therapy, uncomplicated malaria, giardiasis, amebiasis, and trichomoniasis resolve without sequelae.

  • Prevention

    Malaria chemoprophylaxis for travelers: atovaquone-proguanil daily, started 1 to 2 days before travel and continued 7 days after leaving; or mefloquine weekly, started 1 to 2 weeks before and…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.